コンテンツに進む
Save 5% on your next order with code PREMIUM5!
100,000+ Products for Home, Medical, Office & Classroom Needs
Search
商品情報にスキップ
1 1

Process Development of Amlodipine and Olmesartan Medoxomil Tablets - Paperback

$62.05 USD
$62.05 USD
セール 売り切れ
配送料はチェックアウト時に計算されます。
In stock (100 units), ready to be shipped

Available Offers

Fast delivery available on most orders

Multiple secure payment options accepted

Secure checkout with
  • American Express
  • Apple Pay
  • Bancontact
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • PayPal
  • Shop Pay
  • Visa
詳細を表示する

Product Description

by Gayatri Behera (Author), Jayashree Behera (Author), Binapani Barik (Author)

The present study was focused on process development of amlodipine and olmesartan medoxomil tablet 10/40mg. Amlodipine and Olmesartan medoxomil is a combination of a calcium channel blocker and an angiotensin II receptor antagonist used to treat high blood pressure . The Content uniformity was found of both the drugs were performed. Release study was conducted in pH 6.8 buffer media. Furthermore, dissolution profile comparison was carried out using similarity factor (f2) and the similarity factor of Amlodipine and Olmesartan Medoxomil found to be 73. Other studies Like DSC and FTIR studies reported compatibility of Amlodipine besylate with excipients like Cross Carmel lose sodium was performed shows no chemical interaction between drug and excipients. Dissolution profile of Test and Reference standard found to be similar, Similarity factor (f2) is 73.

Number of Pages: 72
Dimensions: 0.17 x 9 x 6 IN
Publication Date: May 14, 2021